Fractyl Health (GUTS) Earnings Analysis
Fractyl Health (GUTS) has no confirmed upcoming earnings date. Last quarter (2026-03-24) it beat with EPS 0.15 USD vs -0.19 USD est (+178.9%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -0.44.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does GUTS next report earnings?
No confirmed upcoming earnings date is currently scheduled for GUTS. This page updates as the calendar is published.
GUTS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-24 | 0.15 USD | -0.19 USD | +178.9% | Beat |
| 2025-11-12 | -0.35 USD | -0.34 USD | -2.9% | Miss |
| 2025-03-03 | -0.52 USD | -0.44 USD | -18.2% | Miss |
| 2024-08-14 | -0.36 USD | -0.46 USD | +21.7% | Beat |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
GUTS valuation and analyst view
| Trailing P/E | -0.44 |
|---|---|
| Trailing EPS | -1.42444 USD |
| Price / book | 2.69 |
| Dividend yield | 0.00% |
| Market cap | 0.06B |
| Analyst consensus | Buy (2 buy / 1 hold / 0 sell) |
| Avg price target | 5 USD |
Related research pages
Frequently asked questions
When is Fractyl Health (GUTS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for GUTS. This page updates as the calendar is published.
Did GUTS beat earnings last quarter?
In its 2026-03-24 report, GUTS posted EPS of 0.15 USD versus a -0.19 USD estimate — a beat of 178.9%.
What is GUTS's earnings track record?
Over the last 4 reported quarters with consensus data, GUTS beat estimates 2 times (50%).
What is GUTS's current P/E ratio and EPS?
GUTS trades at a trailing P/E of -0.44 on trailing EPS of -1.424440213368617 USD.
What do analysts rate GUTS?
Analyst consensus is "Buy" across 3 ratings (0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 5 USD.